{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:53:46Z","timestamp":1793325226836,"version":"4.5.0"},"reference-count":40,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"unspecified","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008271","name":"LEO Pharma Research Foundation","doi-asserted-by":"publisher","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}],"id":[{"id":"10.13039\/501100008271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>While stress plays a paramount role on the onset\/exacerbation of psoriasis, via overactivation of the hypothalamic\u2013pituitary\u2013adrenal axis and increased release of pro-inflammatory cytokines, cutaneous inflammatory response induces, in turn, anxiety\/depression symptoms, via body disfigurement and stigmatisation. The intensity of pruritus and anogenital involvement are additional risk factors for psychological comorbidity.Aims were to (1) examine the effects of intensity of pruritus and anogenital psoriasis on disease burden and psychological comorbidity and (2) identify the variables associated with the presence of clinically significant depression, anxiety, and dysmorphic concerns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Cross-sectional study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Conducted at the University Medical Center Hamburg-Eppendorf (UKE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>107 patients with psoriasis (mean age = 46.3, SD = 14.6 years; 53.3% male): 64 with none\/mild pruritus; 43 with moderate\/severe pruritus; 31 with anogenital psoriasis; 76 not affected in the anogenital area.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary\/secondary outcomes measures<\/jats:title>\n                    <jats:p>Disease severity was assessed with Psoriasis Area and Severity Index and intensity of pruritus was rated by patients. Patient-reported outcomes included the Dermatology Life Quality Index, ItchyQoL, Patient Benefit Index, Perceived Stigmatisation Questionnaire, and Relationship and Sexuality Scale. Psychological morbidity was assessed with the Patient Health Questionnaire, Generalised Anxiety Disorder, and Dysmorphic Concern Questionnaire.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Patients with moderate\/severe pruritus reported more quality of life impairments, depression, anxiety and dysmorphic concerns, and less treatment benefits than those with none\/mild pruritus. Moderate\/severe pruritus had a deleterious effect on depression and stigmatisation for patients without anogenital involvement. Less patient benefits were associated with a higher likelihood of clinically significant depression\/anxiety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Pruritus induces significant burden and psychological morbidity, particularly for patients without anogenital involvement. However, coping strategies used by patients with anogenital psoriasis might be dysfunctional for overall psychosocial adaptation. Patient-centred healthcare might be the best way to prevent psychological comorbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics approval<\/jats:title>\n                    <jats:p>Ethics Committee of the Medical Association of Hamburg (process number PV6083, 28 May 2019).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2021-055477","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:20:39Z","timestamp":1663978839000},"page":"e055477","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":21,"title":["Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns \u2013 a cross-sectional study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-9961","authenticated-orcid":false,"given":"Neuza","family":"da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4026-8728","authenticated-orcid":false,"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-5786","authenticated-orcid":false,"given":"Caroline","family":"Hilbring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6269-5125","authenticated-orcid":false,"given":"Catharina C","family":"Braren-von St\u00fclpnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3080-497X","authenticated-orcid":false,"given":"Rachel","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"2022092321200923000_12.9.e055477.1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0770"},{"key":"2022092321200923000_12.9.e055477.2","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v09n0306"},{"key":"2022092321200923000_12.9.e055477.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06817.x"},{"key":"2022092321200923000_12.9.e055477.4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000448122","article-title":"Major depression and psoriasis: a Psychodermatological phenomenon","volume":"29","author":"Tohid","year":"2016","journal-title":"Skin Pharmacol Physiol"},{"key":"2022092321200923000_12.9.e055477.5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13555-013-0031-0","article-title":"Psoriasis and Psycho-Dermatology","volume":"3","author":"Moon","year":"2013","journal-title":"Dermatol Ther"},{"key":"2022092321200923000_12.9.e055477.6","unstructured":"World Health Organization . Global report on psoriasis 2016."},{"key":"2022092321200923000_12.9.e055477.7","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.508"},{"key":"2022092321200923000_12.9.e055477.8","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/jdv.13891","article-title":"The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials","volume":"31","author":"Fleming","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022092321200923000_12.9.e055477.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bodyim.2016.07.003"},{"key":"2022092321200923000_12.9.e055477.10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2340\/00015555-1975","article-title":"Pruritus in psoriasis: a study of personality traits, depression and anxiety","volume":"95","author":"Remr\u00f6d","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"2022092321200923000_12.9.e055477.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2019.109780","article-title":"Quality of life, anxiety and depressive symptoms in patients with psoriasis: a case-control study","volume":"124","author":"Mart\u00ednez-Ortega","year":"2019","journal-title":"J Psychosom Res"},{"key":"2022092321200923000_12.9.e055477.12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5114\/pdia.2016.62287","article-title":"Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients","volume":"35","author":"\u0141akuta","year":"2018","journal-title":"Postepy Dermatol Alergol"},{"key":"2022092321200923000_12.9.e055477.13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clindermatol.2011.11.004","article-title":"Psychosomatic factors in pruritus","volume":"31","author":"Tey","year":"2013","journal-title":"Clin Dermatol"},{"key":"2022092321200923000_12.9.e055477.14","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0851"},{"key":"2022092321200923000_12.9.e055477.15","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1193"},{"key":"2022092321200923000_12.9.e055477.16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1590\/abd1806-4841.20153254","article-title":"Distribution pattern of psoriasis, anxiety and depression as possible causes of sexual dysfunction in patients with moderate to severe psoriasis","volume":"90","author":"Molina-Leyva","year":"2015","journal-title":"An Bras Dermatol"},{"key":"2022092321200923000_12.9.e055477.17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/PTT.S169389","article-title":"The impact of genital psoriasis on quality of life: a systematic review","volume":"8","author":"Yang","year":"2018","journal-title":"Psoriasis"},{"key":"2022092321200923000_12.9.e055477.18","doi-asserted-by":"crossref","unstructured":"da Silva N , Augustin M , Langenbruch A , et al . Sex-Related impairment and patient needs\/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care. PLoS One 2020;15:e0235091.doi:10.1371\/journal.pone.0235091","DOI":"10.1371\/journal.pone.0235091"},{"key":"2022092321200923000_12.9.e055477.19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/bjd.17147","article-title":"GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis","volume":"180","author":"Larsabal","year":"2019","journal-title":"Br J Dermatol"},{"key":"2022092321200923000_12.9.e055477.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.06.021"},{"key":"2022092321200923000_12.9.e055477.21","doi-asserted-by":"publisher","DOI":"10.1159\/000250839"},{"key":"2022092321200923000_12.9.e055477.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.040"},{"key":"2022092321200923000_12.9.e055477.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"2022092321200923000_12.9.e055477.24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2340\/00015555-1544","article-title":"German version of ItchyQoL: validation and initial clinical findings","volume":"93","author":"Krause","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"2022092321200923000_12.9.e055477.25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00403-012-1256-y","article-title":"Validation of the patient benefit index for the assessment of patient-relevant benefit in the treatment of psoriasis","volume":"304","author":"Feuerhahn","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"2022092321200923000_12.9.e055477.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2004.09.006"},{"key":"2022092321200923000_12.9.e055477.27","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-5-200703060-00004"},{"key":"2022092321200923000_12.9.e055477.28","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00266-018-1183-1","article-title":"The dysmorphic concern questionnaire in the German general population: psychometric properties and normative data","volume":"42","author":"Schieber","year":"2018","journal-title":"Aesthetic Plast Surg"},{"key":"2022092321200923000_12.9.e055477.29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.burns.2016.01.001","article-title":"Validation of the German version of the perceived stigmatization Questionnaire\/Social comfort questionnaire in adult burn survivors","volume":"42","author":"M\u00fcller","year":"2016","journal-title":"Burns"},{"key":"2022092321200923000_12.9.e055477.30","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1200\/JCO.2001.19.11.2788","article-title":"Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study","volume":"19","author":"Berglund","year":"2001","journal-title":"J Clin Oncol"},{"key":"2022092321200923000_12.9.e055477.31","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/jdv.17188","article-title":"Significance of chronic pruritus for intrapersonal burden and interpersonal experiences of stigmatization and sexuality in patients with psoriasis","volume":"35","author":"Sommer","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2022092321200923000_12.9.e055477.32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2340\/00015555-2642","article-title":"Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment","volume":"97","author":"Reich","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"2022092321200923000_12.9.e055477.33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/bjd.17403","article-title":"Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients","volume":"181","author":"Augustin","year":"2019","journal-title":"Br J Dermatol"},{"key":"2022092321200923000_12.9.e055477.34","doi-asserted-by":"crossref","unstructured":"Menard S . Applied logistic regression analysis. 2nd edition. Thousand Oaks, CA: SAGE Publications, Inc, 2002.","DOI":"10.4135\/9781412983433"},{"key":"2022092321200923000_12.9.e055477.35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjd.17208","article-title":"Risk of first-time and recurrent depression in patients with psoriasis: a population-based cohort study","volume":"180","author":"Egeberg","year":"2019","journal-title":"Br J Dermatol"},{"key":"2022092321200923000_12.9.e055477.36","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12909"},{"key":"2022092321200923000_12.9.e055477.37","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-017-0584-6"},{"key":"2022092321200923000_12.9.e055477.38","doi-asserted-by":"publisher","DOI":"10.1159\/000072194"},{"key":"2022092321200923000_12.9.e055477.39","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.6.752"},{"key":"2022092321200923000_12.9.e055477.40","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.337"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2021-055477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T00:21:03Z","timestamp":1663978863000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2021-055477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9,23]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1136\/bmjopen-2021-055477"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2021-055477","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}